JCR Pharmaceuticals Co., Ltd. (OTCMKTS:JCRRF – Get Free Report) dropped 33.8% on Monday . The stock traded as low as $3.1450 and last traded at $3.1450. Approximately 1,000 shares changed hands during mid-day trading, an increase of 100% from the average daily volume of 500 shares. The stock had previously closed at $4.75.
JCR Pharmaceuticals Price Performance
The firm has a 50-day simple moving average of $4.15 and a two-hundred day simple moving average of $4.33.
About JCR Pharmaceuticals
JCR Pharmaceuticals Co, Ltd. is a Japan-based biotechnology company specializing in the development, production and commercialization of plasma-derived products and regenerative medicine solutions. The company focuses on manufacturing high-purity plasma proteins, including human serum albumin, immunoglobulins and coagulation factors, to support a range of therapeutic applications in hematology, immunology and critical care settings.
In its plasma-derived business, JCR leverages state-of-the-art fractionation and purification processes to supply products such as intravenous immunoglobulin and albumin formulations.
Further Reading
- Five stocks we like better than JCR Pharmaceuticals
- Marvell’s AI Moment Raises a Bigger Question for Amazon and ServiceNow
- Palo Alto Networks Accelerates Growth 31% on AI Demand
- NVIDIA, Marriott, and PCA Just Delivered Big News for Income Investors
- Motorola’s $1.5B Bet to Own the Skies
Receive News & Ratings for JCR Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for JCR Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
